Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-Current Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Non-Current Assets for 16 consecutive years, with $28.0 million as the latest value for Q3 2025.

  • Quarterly Non-Current Assets rose 1.89% to $28.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $109.3 million through Sep 2025, changed 0.07% year-over-year, with the annual reading at $26.7 million for FY2024, 3.68% down from the prior year.
  • Non-Current Assets for Q3 2025 was $28.0 million at Xtant Medical Holdings, roughly flat from $27.9 million in the prior quarter.
  • The five-year high for Non-Current Assets was $28.0 million in Q3 2025, with the low at $10.2 million in Q3 2021.
  • Average Non-Current Assets over 5 years is $20.1 million, with a median of $26.6 million recorded in 2024.
  • The sharpest move saw Non-Current Assets skyrocketed 156.76% in 2023, then decreased 3.68% in 2024.
  • Over 5 years, Non-Current Assets stood at $10.4 million in 2021, then rose by 5.3% to $10.9 million in 2022, then soared by 154.27% to $27.7 million in 2023, then decreased by 3.68% to $26.7 million in 2024, then increased by 4.75% to $28.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $28.0 million, $27.9 million, and $26.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.